All News

Brain magnetic resonance imaging (MRI) can be used to identify people with attention-deficit/hyperactivity disorder from patients without the condition, according to a new study.

While African Americans are 3 times more likely than Caucasians to be diagnosed with multiple myeloma (MM)—and twice as likely to die of the disease—they are underrepresented in MM disease research.

A meta-analysis finds a connection between atopic dermatitis and occupational hand eczema.

A look at the millions of tax filers who chose the penalty over insurance coverage; the cost of unnecessary or excessively expensive medical care; Takeda begins the first Zika vaccine trial.

High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.

Health insurers warned that giving states the ability to define their own essential health benefits will confuse consumers and undermine the insurance markets.

Physical activity, even of a low-intensity, reduces the risk of cardiovascular disease in older adults, according to a study published in The European Journal of Preventive Cardiology. Although the authors found similar associations for individuals under age 55 and individuals aged 55-65, the results were not statistically significant.

A newly published study finds that oral glucocorticoid use has decreased over time, with both reduced initiation and increased cessation of treatment with these drugs.

A study published in CA: A Cancer Journal for Clinicians found that 42% of all incident cancer cases in US adults age 30 years or older in 2014 were attributable to potentially modifiable exposures. Exposures included smoking, alcohol intake, physical inactivity, and low fiber intake.

New skinny plans cause confusion in the healthcare marketplace; the health risks associated with frequent travel need to be studied more; a doctor lacking computer skills loses license to practice.

Patients are significantly overestimating the pain they will feel after surgery, indicating that providers can do a better job of educating patients on what they can expect.

A study published in JAMA Oncology found that a significant number of patients newly diagnosed with cancer have had a prior cancer. The prevalence differed among age group and incident cancer type.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved $57 million to support 14 new comparative clinical effectiveness research studies, including studies on dementia, prostate cancer, and anxiety disorders.

The review period in the report bridged a public scandal at the VA that forced the resignation of a former Cabinet secretary.

A study published in Breast Cancer Research found that smoking is associated with a significant increased risk of breast cancer, especially in women who started smoking during adolescence or who have a family history of the disease.

The research shows that giving patients support to keep weight off after surgery is key to maintaining diabetes remission.

Some states prepare to end the Children's Health Insurance Program with no new funding; shifting healthcare landscape reveals odd partnerships; Affordable Care Act sign-ups slow in third week of open enrollment.

A new tool developed by the Agency for Healthcare Research and Quality and the ECRI Institute will assess the extent to which a guideline adheres to the Institute of Medicine’s (IOM) standards for trustworthy evidence-based clinical guidelines.

A recently remeleased rule proposal for Medicare Advantage would give plans greater flexibiilty around the uniformity requirement and allow for the implementation of value-based insurance design principles.

Patients might be able to avoid or better manage surprise ambulance bills; Brexit causes providers to leave London and prevents others from entering Britain at all; new research provides insight on antibiotic resistance.

The “nocebo” effect, a phenomenon that occurs when a patient’s negative perception of a therapy causes a treatment to have a worse outcome than would otherwise be expected, has become a topic of increasing interest in the world of biosimilars as some patients begin to transition from familiar, high-cost biologics to new, lower-cost biosimilars.

This week, the top managed care stories included a new rule from CMS to address drug costs for seniors; a campaign to get payers to fund the artificial pancreas is working; and a new survey identifies how Americans prefer to treat pain.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study published in JAMA Internal Medicine found that blood pressure (BP) lowering is associated with reduced risk of death and cardiovascular disease (CVD) if the baseline systolic blood pressure (SBP) is 140 mm Hg or higher. Treatment may be considered in patients with coronary heart disease and SBP under 140 mm Hg, but not for primary prevention.

This Thanksgiving, families will discuss of end-of-life care wishes; FDA provides new guidance for development of abuse-deterrent opioids; Missouri reverses its restrictive policy in Medicaid for hepatitic C medicine.

Chief Togetherness Officer Robin Caruso, LCSW, highlights early successes of CareMore's program to address lonelineness in the senior population.

The National Center for Health Statistics has issued its early estimates from the National Health Interview Survey, conducted between January and June 2017. The report presents selected estimates, based on data for 39,480 people in the first 6 months of the year, on health insurance coverage for the US population.

Roche is suing Pfizer to block the company from selling a biosimilar referencing its breast-cancer drug Herceptin in the United States, claiming that the biosimilar infringes on 40 of its patents.

Consolidation is happening all throughout the healthcare industry in the United States, but the shift to consolidation in dermatology began to pick up speed in just the last 3 to 5 years and it has been driven by private investors, according to a new Viewpoint in JAMA Dermatology.